September 5, 2008 - Pathway Medical Technologies Inc., today received FDA clearance to market Jetstream, a peripheral atherectomy catheter designed for use in the treatment of peripheral artery disease (PAD) in the lower limbs.

September 5, 2008 - The results of the SYNTAX study, a head-to-head comparison between drug-eluting stents (DES) using percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in patients with complex coronary disease, showed bypass is a better option.

The results were announced Sept. 1 at the annual European Society of Cardiology meeting in Munich, Germany.

Vascular Solutions will partner with Radius Medical Technologies for the U.S. launch of the MICRO Elite Snare, a device designed for the retrieval and manipulation of foreign bodies located in the coronary and peripheral cardiovascular system and the extra-cranial neurovascular anatomy, which Vascular Solutions will distribute exclusively in the U.S.

Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), which is used with Biotronik Home Monitoring to enable continuous automatic daily data transmission of the patient’s cardiovascular status via the Internet.

Cardiac Science launched its HeartCentrix 6.2 data management product for the physician office to connect Burdick and Quinton equipment to an electronic medical record (EMR) system.
The connectivity gives access to test results remotely and across locations with a single sign-on from within the EMR itself.


In as much as the environment in which you live can affect your quality of life, so can the environment in which someone receives medical care affect patient outcome – at least in theory.

Tight inventory control in the cath and electrophysiology (EP) labs is critical to hospitals' bottom lines due to the expense of the items and their rapid expirations. A new technology showing big returns on investment is radio-frequency identification (RFID) tracking.


The landscape of cardiovascular care is changing. In the cath lab alone, the shift in volume and type of diagnostic and interventional procedures has broadened the lab’s scope, increased demand and raised expectations.

The process of the coronary CT angiography (CTA) becoming the preferred imaging modality is akin to the process of obtaining a pilot’s license.

While the primary reason hospitals adopt new technology is to increase patient care and produce better outcomes, there are many other factors that also affect purchasing decisions.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now